Reversal of the inhibitory effects of calcitonin gene-related peptide (CGRP) and amylin on insulin secretion by the 8-37 fragment of human CGRP

• Published in: Biochemical pharmacology Vol. 45; no. 11; p. 2343
• Main Authors: Silvestre, R A, Salas, M, Dégano, P, Peiró, E, Marco, J
• Format: Journal Article
• Language: English
• Published: England 09-06-1993
• Subjects: Amyloid - antagonists & inhibitors; Amyloid - pharmacology; Animals; Calcitonin Gene-Related Peptide - antagonists & inhibitors; Calcitonin Gene-Related Peptide - pharmacology; Glucose - antagonists & inhibitors; Insulin - metabolism; Insulin Secretion; Islet Amyloid Polypeptide; Male; Pancreas - drug effects; Pancreas - metabolism; Peptide Fragments - pharmacology; Perfusion; Rats; Rats, Wistar
• ISSN: 0006-2952
• DOI: 10.1016/0006-2952(93)90209-F

The 8-37 fragment of human calcitonin gene-related peptide [(8-37)hCGRP] antagonizes the effects of calcitonin gene-related peptide (CGRP) and amylin in a number of tissues. We have studied the influence of (8-37)hCGRP on the effects of both CGRP and amylin on insulin secretion. In the perfused rat pancreas, homologous CGRP and amylin, at 75 pM, exerted comparable inhibitory effects on the insulin response to 9 mM glucose (ca. 70%; P < 0.025). These effects were antagonized by (8-37)hCGRP (1 microM). Our results suggest that CGRP and amylin act on the B-cell, at least in part, through a common receptor.